Page last updated: 2024-08-18

dilactide and lxt-101

dilactide has been researched along with lxt-101 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, L; Jin, Y; Li, X; Mei, X; Wang, C; Zhang, F1

Other Studies

1 other study(ies) available for dilactide and lxt-101

ArticleYear
In-vitro/in-vivo studies of the biodegradable poly-(D,L-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment.
    Anti-cancer drugs, 2011, Volume: 22, Issue:3

    Topics: Animals; Antineoplastic Agents; Dioxanes; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Lactic Acid; Male; Microspheres; Oligopeptides; Orchiectomy; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Prostate; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Testis; Testosterone

2011